Evidence map›Paper›PMID 39770126›Full record

ArticleMolecules (Basel, Switzerland)2024

Nanoconfined Chlorine-Substituted Monomethine Cyanine Dye with a Propionamide Function Based on the Thiazole Orange Scaffold-Use of a Fluorogenic Probe for Cell Staining and Nucleic Acid Visualization.

Nikolay Ishkitiev, Maria Micheva, Marina Miteva, Stefaniya Gaydarova, Christo Tzachev, Vesela Lozanova, Valentin Lozanov, Diana Cheshmedzhieva, Meglena Kandinska, Sonia Ilieva and 8 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nikolay IshkitievDepartment of Medical Chemistry and Biochemistry, Medical University Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.ORCID 0000-0002-4351-5579
Maria MichevaMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.ORCID 0009-0000-0897-5951
Marina MitevaDepartment of Medical Chemistry and Biochemistry, Medical University Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.ORCID 0000-0002-3910-5147
Stefaniya GaydarovaFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.
Christo TzachevFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0003-2991-460X
Vesela LozanovaDepartment of Medical Chemistry and Biochemistry, Medical University Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.ORCID 0000-0002-7748-4133
Valentin LozanovDepartment of Medical Chemistry and Biochemistry, Medical University Sofia, 2 Zdrave Str., 1431 Sofia, Bulgaria.
Diana CheshmedzhievaFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-9344-9282
Meglena KandinskaFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-0426-2820
Sonia IlievaFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0002-3911-7287
Raimundo GargalloDepartment of Chemical Engineering and Analytical Chemistry, University of Barcelona, Martí i Franqués 1-11, E-08028 Barcelona, Spain.ORCID 0000-0001-8716-8356
Stanislav BaluschevMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.ORCID 0000-0002-0742-0687
Stoyno StoynovInstitute of Molecular Biology ''Roumen Tsanev,'' Bulgarian Academy of Sciences, ''Acad. George Bonchev'' Str. 21, 1113 Sofia, Bulgaria.
Teodora Dyankova-DanovskaInstitute of Molecular Biology ''Roumen Tsanev,'' Bulgarian Academy of Sciences, ''Acad. George Bonchev'' Str. 21, 1113 Sofia, Bulgaria.
Marina Nedelcheva-VelevaInstitute of Molecular Biology ''Roumen Tsanev,'' Bulgarian Academy of Sciences, ''Acad. George Bonchev'' Str. 21, 1113 Sofia, Bulgaria.
Katharina LandfesterMax Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany.ORCID 0000-0001-9591-4638
Zornitsa MihaylovaDepartment of Oral and Maxillofacial Surgery, Medical University Sofia, 1 "G. Sofijski" Str., 1431 Sofia, Bulgaria.
Aleksey VasilevFaculty of Chemistry and Pharmacy, Sofia University "St. Kliment Ohridski", 1 James Bourchier Blvd., 1164 Sofia, Bulgaria.ORCID 0000-0003-2199-5644

Funding

European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria project SUMMIT BG-RRP-2.004-0008-C01RG acknowledges a grant from the Spanish Ministerio de Ciencia, Innovación y Universidades funded by MCIN/AEI/10.13039/501100011033 and "ERDF A way of making Europe". PID2023-146465NB-I00
6 · The paper itself

Abstract

The development of fluorescence-based methods for bioassays and medical diagnostics requires the design and synthesis of specific markers to target biological microobjects. However, biomolecular recognition in real cellular systems is not always as selective as desired. A new concept for creating fluorescent biomolecular probes, utilizing a fluorogenic dye and biodegradable, biocompatible nanomaterials, is demonstrated. The synthesis of a new dicationic asymmetric monomethine cyanine dye with benzo[d]thiazolium-N-propionamide and chloroquinoline end groups is presented. The photophysical properties of the newly synthesized dye were examined through the combined application of spectroscopic and theoretical methods. The applicability of the dye as a fluorogenic nucleic acid probe was proven by UV-VIS spectroscopy and fluorescence titration. The dye-nucleic acid interaction mode was investigated by UV-Vis and CD spectroscopy. The newly synthesized dicationic dye, like other similar fluorogenic structures, limited permeability, which restricts its use as a probe for RNA and DNA. To enhance cellular delivery, we utilized a patented technology that employs solid, insoluble lipid nanoparticles. This method ensures the complete introduction of the dye into cells while minimizing activity outside the cells. In our study involving two human cell lines, we observed improved penetration through the cell membrane and distinctive selectivity in visualizing nucleic acids within the cytoplasm and nucleus.

Indexed as

BenzothiazolesFluorescent DyesQuinolinesCarbocyaninesChlorineDNAHumansNanoparticlesNucleic AcidsSpectrometry, FluorescenceStaining and LabelingBenzothiazolesCarbocyaninesChlorineDNAFluorescent DyesNucleic AcidsQuinolinesthiazole orangeCDcyanineDFTdyelipidmonomethinenanoparticlessolidTDDFT

Identifiers

PMID39770126
PMCPMC11677322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.